ArticleThe journal of headache and pain2025

Long-term effectiveness of fremanezumab in episodic and chronic migraine patients in clinical routine - 24-months results from the prospective non-interventional FINESSE study.

Andreas Straube et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.